Report Feature
The material technologies in implantable device has undergone significant change in recent years, with metal to ceramic based implantable device. The rising wave of new material technologies such as metallic and ceramic bio material are creating significant potential for advanced implantable device in various medical platforms due to its favorable mechanical strength, excellent friction-resistance, biocompatibility, and durability.
In implantable device market, various material technologies such as polymer, metal, ceramic, and biologics are used in the orthopedic, dental, facial, breast, and cardiovascular implant applications. Growing elderly population, rise in prevalence of chronic diseases, and rise in incidence of obesity and osteoporosis-related fractures are creating new opportunities for various implantable device technologies.
Some of the latest technological developments by various countries in the implantable device market are as follows:
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global implantable device technology by application, technology, and region as follows:
Technology Readiness by Material Technology
Competitive Intensity and Regulatory Compliance
Disruption Potential by Material Technology
Trends and Forecasts by Material Technology [$M shipment analysis from 2018 to 2030]:
Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:
Technology Trends and Forecasts by Region [$M shipment analysis for 2018 – 2030]:
Latest Developments and Innovations in the Implantable Device Technologies
Companies / Ecosystems
Strategic Opportunities by Material Technology
Some of the implantable device companies profiled in this report include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardinal Health, Conmed Corporation, Globus Medical, Integra Lifesciences Holdings Corporation, Johnson & Johnson, and LivaNova.
Below are the latest technological developments from top companies in the implantable device market:
Q.1 What are some of the most promising and high-growth technology opportunities for the implantable device market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in implantable device market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in implantable device market?
Q.6 What are the latest developments in implantable device technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this implantable device market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this implantable device technology space?
In implantable device market, various material technologies such as polymer, metal, ceramic, and biologics are used in the orthopedic, dental, facial, breast, and cardiovascular implant applications. Growing elderly population, rise in prevalence of chronic diseases, and rise in incidence of obesity and osteoporosis-related fractures are creating new opportunities for various implantable device technologies.
Some of the latest technological developments by various countries in the implantable device market are as follows:
- United States: Medtronic announced FDA approval of their new dissolvable polymer stent designed to treat coronary artery blockages. This minimally invasive technology aims to reduce long-term complications associated with permanent stents. Zimmer Biomet, a leading orthopedic implant manufacturer, is investing heavily in research on bone graft substitutes using 3D-printed biocompatible scaffolds. This technology has the potential to revolutionize bone regeneration procedures.
- China: Chinese companies like Beijing Wanxiang Qianfeng are focusing on developing affordable and high-quality metal knee and hip implants. Government initiatives are promoting domestic production to reduce reliance on foreign imports.
- Germany: CeramTec is at the forefront of developing ceramic spinal implants that offer superior biocompatibility and wear resistance compared to traditional metal options. This research is expected to improve the long-term success rates of spinal fusion surgeries.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global implantable device technology by application, technology, and region as follows:
Technology Readiness by Material Technology
Competitive Intensity and Regulatory Compliance
Disruption Potential by Material Technology
Trends and Forecasts by Material Technology [$M shipment analysis from 2018 to 2030]:
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:
-
Orthopedic Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
-
Dental Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
-
Facial Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
-
Breast Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
-
Cardiovascular Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
Technology Trends and Forecasts by Region [$M shipment analysis for 2018 – 2030]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- Japan
- China
- South Korea
- India
- The Rest of the World
Latest Developments and Innovations in the Implantable Device Technologies
Companies / Ecosystems
Strategic Opportunities by Material Technology
Some of the implantable device companies profiled in this report include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardinal Health, Conmed Corporation, Globus Medical, Integra Lifesciences Holdings Corporation, Johnson & Johnson, and LivaNova.
Below are the latest technological developments from top companies in the implantable device market:
- Johnson & Johnson (J&J) received FDA approval for their new generation of XELIUS™ hip implant, featuring a proprietary polymer coating designed to improve wear resistance and longevity.
- Stryker Corporation announced a $50 million capital expenditure plan to expand their manufacturing capacity for BioFlex® patient-specific knee implants, a polymer-based solution for total knee replacements.
- Zimmer Biomet partnered with the National Institute of Standards and Technology (NIST) to develop new standards for characterizing the surface properties of metal-based knee implants, aiming to improve long-term performance.
- The German Federal Ministry of Education and Research awarded ExplantLab a grant to develop a novel metal-based spinal implant with an antibacterial surface coating, potentially reducing infection risks.
- CeramTec GmbH launched their CeraDur® Acetabular Cup System, a ceramic-on-ceramic hip replacement solution boasting exceptional wear resistance and biocompatibility.
- Smith & Nephew received regulatory approval in China for their OXinium® zirconia knee implant, expanding their reach in the high-growth Asian market for ceramic-based implants.
- Medtronic acquired InBone Technologies, a company specializing in bone graft substitutes derived from natural biomaterials, strengthening their position in the biologics segment.
- Ossur partnered with a consortium of universities in Europe to research and develop next-generation biocompatible materials for spinal fusion procedures.
Q.1 What are some of the most promising and high-growth technology opportunities for the implantable device market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in implantable device market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in implantable device market?
Q.6 What are the latest developments in implantable device technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this implantable device market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this implantable device technology space?
Table of Contents
1. Executive Summary 2. Technology Landscape 2.1. Technology Background and Evolution 2.2. Technology and Application Mapping 2.3. Supply Chain
3. Technology Readiness 3.1. Technology Commercialization and Readiness 3.2. Drivers and Challenges in Implantable Device Technologies 3.3. Competitive Intensity 3.4. Regulatory Compliance
4. Technology Trends and Forecasts Analysis from 2018-2030 4.1. Implantable Device Opportunity 4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
5. Technology Opportunities (2018-2030) by Region 5.1. Implantable Device Market by Region 5.2. North American Implantable Device Technology Market
6. Latest Developments and Innovations in the Implantable Device Technologies 7. Companies / Ecosystem 7.1. Product Portfolio Analysis 7.2. Market Share Analysis 7.3. Geographical Reach
8. Strategic Implications 8.1. Implications 8.2. Growth Opportunity Analysis
9. Company Profiles of Leading Players 9.1. Abbott Laboratories 9.2. Biotronik 9.3. Boston Scientific Corporation 9.4. Cardinal Health 9.5. Conmed Corporation 9.6. Globus Medical 9.7. Integra Lifesciences Holdings Corporation 9.8. Johnson & Johnson 9.9. LivaNova
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
